JP2023542453A5 - - Google Patents
Info
- Publication number
- JP2023542453A5 JP2023542453A5 JP2023502638A JP2023502638A JP2023542453A5 JP 2023542453 A5 JP2023542453 A5 JP 2023542453A5 JP 2023502638 A JP2023502638 A JP 2023502638A JP 2023502638 A JP2023502638 A JP 2023502638A JP 2023542453 A5 JP2023542453 A5 JP 2023542453A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- group
- seq
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025136537A JP2025170319A (ja) | 2020-07-14 | 2025-08-19 | Ｓａｒｓ－ｃｏｖ－２阻害剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063051474P | 2020-07-14 | 2020-07-14 | |
| US63/051,474 | 2020-07-14 | ||
| US202063067593P | 2020-08-19 | 2020-08-19 | |
| US63/067,593 | 2020-08-19 | ||
| PCT/US2021/034069 WO2022015418A1 (en) | 2020-07-14 | 2021-05-25 | Sars-cov-2 inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025136537A Division JP2025170319A (ja) | 2020-07-14 | 2025-08-19 | Ｓａｒｓ－ｃｏｖ－２阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542453A JP2023542453A (ja) | 2023-10-10 |
| JP2023542453A5 true JP2023542453A5 (https=) | 2024-06-03 |
Family
ID=76808129
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502638A Pending JP2023542453A (ja) | 2020-07-14 | 2021-05-25 | Ｓａｒｓ－ｃｏｖ－２阻害剤 |
| JP2025136537A Pending JP2025170319A (ja) | 2020-07-14 | 2025-08-19 | Ｓａｒｓ－ｃｏｖ－２阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025136537A Pending JP2025170319A (ja) | 2020-07-14 | 2025-08-19 | Ｓａｒｓ－ｃｏｖ－２阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230250134A1 (https=) |
| EP (1) | EP4182027A1 (https=) |
| JP (2) | JP2023542453A (https=) |
| KR (1) | KR20230038485A (https=) |
| CN (1) | CN116209672A (https=) |
| AU (1) | AU2021308208A1 (https=) |
| WO (1) | WO2022015418A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202317599A (zh) * | 2021-07-07 | 2023-05-01 | 國立大學法人東京醫科齒科大學 | 具有抗病毒活性之胜肽、包含該胜肽之抗病毒劑、該抗病毒劑之製造方法 |
| KR20240177843A (ko) * | 2023-06-20 | 2024-12-30 | 주식회사 엔큐라젠 | SARS-CoV-2스파이크 단백질에 특이적으로 결합하는 펩타이드 및 이의 용도 |
| WO2025101453A1 (en) * | 2023-11-07 | 2025-05-15 | University Of Washington | De novo design of potent minibinder antagonists of il-6r, gp130, and il1-r1 |
| WO2025221716A1 (en) * | 2024-04-17 | 2025-10-23 | University Of Washington | Smart mhc: a de-novo designed platform for soluble expression of peptide-receptive class-i mhc in e. coli |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6900033B2 (en) * | 2001-06-04 | 2005-05-31 | Human Genome Sciences, Inc. | Methods and compositions for modulating ACE-2 activity |
| CA3178016A1 (en) * | 2020-05-27 | 2021-12-02 | University Of Washington | Modular and generalizable biosensor platform based on de novo designed protein switches |
-
2021
- 2021-05-25 CN CN202180049677.2A patent/CN116209672A/zh active Pending
- 2021-05-25 KR KR1020237001812A patent/KR20230038485A/ko active Pending
- 2021-05-25 AU AU2021308208A patent/AU2021308208A1/en active Pending
- 2021-05-25 US US18/004,545 patent/US20230250134A1/en active Pending
- 2021-05-25 WO PCT/US2021/034069 patent/WO2022015418A1/en not_active Ceased
- 2021-05-25 JP JP2023502638A patent/JP2023542453A/ja active Pending
- 2021-05-25 EP EP21739198.6A patent/EP4182027A1/en active Pending
-
2025
- 2025-08-19 JP JP2025136537A patent/JP2025170319A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023542453A5 (https=) | ||
| JP2023506765A5 (https=) | ||
| JP2022115876A5 (https=) | ||
| IL321500A (en) | Pre-stabilized hmpv f proteins | |
| JP2023522249A5 (https=) | ||
| JP2023518038A5 (https=) | ||
| JP2023512519A5 (https=) | ||
| JP2023544834A5 (https=) | ||
| JP2021512126A5 (https=) | ||
| ES2210255T3 (es) | Metodos para mejorar la actividad biologica de quimiocinas. | |
| JP2023524054A5 (https=) | ||
| JP2025184979A5 (https=) | ||
| JP2020023567A5 (https=) | ||
| RU2018100181A (ru) | Модифицированный белок интерлейкина-7 и способы его применения | |
| JP2009520463A5 (https=) | ||
| JP2023528207A5 (https=) | ||
| JP2005520834A5 (https=) | ||
| JP2008507298A5 (https=) | ||
| CN121343934A (zh) | 对补体灭活作用具有抗性的用于治疗癌症的包膜病毒 | |
| JP2024533316A5 (https=) | ||
| JP2025170319A (ja) | Ｓａｒｓ－ｃｏｖ－２阻害剤 | |
| JP2018537089A5 (https=) | ||
| JP2026035742A5 (https=) | ||
| JP2023522154A5 (https=) | ||
| JP2001526242A (ja) | Ｉｆｎａｒ２／ｉｆｎ複合体 |